Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5745 - 5752 of 12089 results
United States-Mexico-Canada Agreement Announced
October 3, 2018| Alert| Viewpoint
Delaware Court Finds “Material Adverse Effect” Allows Buyer to Terminate Merger Agreement
October 3, 2018| Advisory| Viewpoint
Joining IP Hiring Wave, Mintz Adds Ex-Practice Chair at Curtis
October 3, 2018| News
Final Opioid Package: A Comparison of the House Package, Senate Package, and the Final Version
October 2, 2018| Blog| Viewpoint
Head of the Antitrust Division of the Department of Justice Announces Plan to Expedite the Merger Review Process and Put DOJ on a 6 Month Shot Clock
October 2, 2018| Advisory| Viewpoint
Association Health Plan Perspectives (Part 2): The Look-Through Rule and the Limits of State Regulatory Power
October 2, 2018| Blog| Viewpoint
New York State Department of Labor Releases Final Guidance Just Ahead of October 9, 2018 Compliance Deadline
October 2, 2018| Blog| Viewpoint
DV-2020 Diversity Visa Registration to Open
October 2, 2018| Advisory| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|